Recursion Pharmaceuticals (RXRX) Tax Rate (2023 - 2026)

Recursion Pharmaceuticals has reported Tax Rate for 4 years, with the latest figure at 3.77% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate rose 369.0% year-over-year to 3.77%; the trailing twelve-month figure through Mar 2026 stood at 0.81% (up 72.0% YoY), and the FY2025 full-year result was 0.02%, down 22.0% from the prior year.
• Tax Rate for Q1 2026 stood at 3.77%, up from 0.02% in the prior quarter.
• The five-year high for Tax Rate was 4.19% in Q4 2023, with the low at 0.17% in Q3 2024.
• Historically, Tax Rate has averaged 1.02% across 4 years, with a median of 0.08% in 2025.
• Annual changes were most pronounced in 2024 — Tax Rate slumped 419 bps — and 2026, when it surged 369 bps.
• Recursion Pharmaceuticals' Tax Rate stood at 4.19% in 2023, then sank by 100 bps to 0.0% in 2024, then sank by 373 bps to 0.02% in 2025, then soared by 20480 bps to 3.77% in 2026.
• The last three Tax Rate figures came in at 3.77% (Q1 2026), 0.02% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.